Available
$85.00
Strict Regulatory Notice: This agent is synthesized strictly for laboratory-based research and analytical purposes. It is not intended for human or veterinary use, nor for medical, household, or cosmetic applications. Please review our Terms of Service thoroughly before finalizing your acquisition.
Available
| Category | Parameter | Specification / Details |
|---|---|---|
| Identification & Nomenclature | Primary Compound Name | Tesamorelin (GHRH Analog) |
| CAS Registry Number | 218949-48-5 | |
| Sequence / IUPAC | trans-3-Hexenoyl-GHRH (1-44) | |
| Chemical & Physical Properties | Molecular Formula | C211H366N72O67S |
| Molar Mass / Weight | 5135.9 g/mol | |
| Physical Appearance | White lyophilized (freeze-dried) solid/powder | |
| Solubility Profile | Highly soluble in Bacteriostatic Water and sterile water. | |
| Product Specifications | Tested Purity | ≥98% via HPLC |
| Active Ingredient (Total) | 10mg per vial | |
| Dry / Powder Formulations | Lyophilized powder | |
| Handling & Logistics | Storage Guidelines | Lyophilized: Store at -20°C for long-term stability. Protect from light.Reconstituted: Must be refrigerated at 2°C to 8°C. |
| Estimated Shelf Life | 24 months from manufacture date (lyophilized). | |
| Terms of Application | For laboratory research purposes only. Not for human or veterinary use. Investigated as a stabilized Growth Hormone-Releasing Hormone (GHRH) analog to evaluate basal GH pulsatility, lipid metabolism, and visceral adiposity reduction in cellular and in-vitro models. |
Tesamorelin (10mg) is a prominent subject within the field of neuroendocrinology and highly specific lipolytic modeling. Synthesized as a synthetic analogue of growth hormone-releasing factor (GRF) with a trans-3-hexenoic acid moiety, it serves researchers examining the direct stimulation of pituitary somatotrophs and the targeted reduction of visceral adipose tissue in-vitro.
At 4 Amino Labs, we provide this compound in a highly pure format to ensure experimental reproducibility. By maintaining rigorous measurement standards, we provide the consistency required for longitudinal data integrity.
Scientific Literature Reference: The biochemical capacity of this modified GRF analog to elevate basal insulin-like growth factor 1 (IGF-1) levels and specifically mobilize visceral fat depots is heavily documented. See: Falutz, J., et al. (2007). “Metabolic effects of a growth hormone-releasing factor in patients with HIV.” New England Journal of Medicine, 357(23), 2359-2370.
Our Tesamorelin undergoes a multifaceted verification process. Each batch is subjected to independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to ensure a purity threshold of ≧ 99%.
Researchers utilizing Tesamorelin typically focus on the following biochemical mechanisms:
To maintain the molecular integrity of Tesamorelin, the following storage parameters are recommended:
This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4 Amino Lab does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.
